Quotient

Quotient EBIT

Delisted

The EBIT of Quotient (QTNT) as of Nov 9, 2026 is -92.22 M USD. In the previous year, EBIT was -82.51 M USD — a change of 11.76% (lower).

EBIT

-92.22 MUSD

YoY

11.76%

Last updated:

In 2022, Quotient's EBIT was -92.22 M USD, a 11.76% increase from the -82.51 M USD EBIT recorded in the previous year.

The Quotient EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
-78.96 M USD
Jan 1, 2020
-80.69 M USD
Jan 1, 2021
-82.51 M USD
Jan 1, 2022
-92.22 M USD
Jan 1, 2023 (e)
-94.37 M USD
Jan 1, 2024 (e)
-76.66 M USD
Jan 1, 2025 (e)
-85.63 M USD
Jan 1, 2026 (e)
-97.56 M USD
The Quotient EBIT history
YEAREBITYoY
est-97.56 MUSD+13.94%
est-85.63 MUSD+11.70%
est-76.66 MUSD-18.77%
est-94.37 MUSD+2.34%
-92.22 MUSD+11.76%
-82.51 MUSD+2.25%
-80.69 MUSD+2.20%
-78.96 MUSD+16.76%
-67.62 MUSD-10.04%
-75.17 MUSD+53.13%
-49.09 MUSD+65.20%
-29.71 MUSD+234.17%
-8.89 MUSD+98.00%
-4.49 MUSD+13.29%
-3.96 MUSD-3.29%
-4.10 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quotient Revenue

Quotient Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
29.13 M USD
-78.96 M USD
-105.39 M USD
Jan 1, 2020
32.66 M USD
-80.69 M USD
-102.77 M USD
Jan 1, 2021
43.38 M USD
-82.51 M USD
-108.47 M USD
Jan 1, 2022
38.51 M USD
-92.22 M USD
-125.13 M USD
Jan 1, 2023 (e)
39.40 M USD
-94.37 M USD
-6.65 B USD
Jan 1, 2024 (e)
54.90 M USD
-76.66 M USD
-4.87 B USD
Jan 1, 2025 (e)
102.10 M USD
-85.63 M USD
-115.63 M USD
Jan 1, 2026 (e)
146.17 M USD
-97.56 M USD
-145.44 M USD

Quotient Margins

Quotient stock margins

The Quotient margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Quotient. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Quotient.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
40.86 %
-271.01 %
-361.73 %
Jan 1, 2020
45.49 %
-247.09 %
-314.71 %
Jan 1, 2021
53.72 %
-190.20 %
-250.05 %
Jan 1, 2022
38.80 %
-239.43 %
-324.89 %
Jan 1, 2023 (e)
38.80 %
-239.53 %
-16,874.41 %
Jan 1, 2024 (e)
38.80 %
-139.63 %
-8,872.60 %
Jan 1, 2025 (e)
38.80 %
-83.87 %
-113.24 %
Jan 1, 2026 (e)
38.80 %
-66.75 %
-99.50 %

Quotient Stock analysis

What does Quotient do? Quotient Ltd is a biopharmaceutical company headquartered in Eysins, Switzerland. The company was founded in 2007 with the aim of developing innovative technologies in the field of Personalized Medicine. This means that medications and therapies are specifically tailored to the individual needs of patients. Thanks to state-of-the-art production processes, products can be produced quickly and safely. Quotient Ltd has a unique business model based on transfusion technology. This technology allows the company to produce medications quickly and accurately. The different components of the medications are separated and then combined in the required dosage. This means that the medications can be precisely dosed and the risks of side effects minimized. A key focus of Quotient Ltd is the development of therapeutics. Personalized medicine and the fast and safe production of medications are at the center of this area. The transfusion technology enables medications to be produced quickly and flexibly, which is particularly important for rare diseases and personalized therapies. Another important area is the development of diagnostics. These enable diseases to be diagnosed quickly and safely. Based on this diagnosis, suitable therapies are then developed. Quotient Ltd also relies on transfusion technology for this, which enables fast, reliable, and flexible production of diagnostics. In addition to its developed technology and know-how, Quotient Ltd also has its own production facility. Here, all products are produced to the highest standards. The production facility covers an area of approximately 6,000 square meters. The modern facility is equipped with the latest technologies and meets the highest quality standards. Quotient Ltd offers a variety of products, with a special focus on personalized medicine and the fast and safe production of medications and diagnostics. One example is the PDA diagnostic system, which was developed for the fast and accurate diagnosis of autoimmune diseases. The MosaiQ system is another important product that enables fast and reliable production of medications. The success story of Quotient Ltd is closely linked to the development of transfusion technology. The company has succeeded in developing a technology that allows for the fast and safe production of personalized medicine. This technology has made Quotient Ltd a leading company in the field of personalized medicine worldwide. Today, Quotient Ltd employs over 700 people who are constantly working on the further development of personalized medicine and transfusion technology. Quotient is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Quotient's EBIT

Quotient's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Quotient's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Quotient's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Quotient’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Quotient stock

EBIT of Quotient is -92.22 M USD in 2022.

EBIT of Quotient changed from -82.51 M USD to -92.22 M USD, representing a 11.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Quotient since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Quotient historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Quotient

All Key Metrics — Quotient